AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,922,000 | +104.2% | 457,539 | +1.3% | 0.00% | +100.0% |
| Q2 2022 | $3,390,000 | -15.7% | 451,857 | +2.3% | 0.00% | 0.0% |
| Q1 2022 | $4,021,000 | +24.1% | 441,856 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $3,241,000 | -38.6% | 461,724 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $5,276,000 | -31.4% | 462,775 | -3.6% | 0.00% | 0.0% |
| Q2 2021 | $7,687,000 | -5.0% | 480,138 | +6.0% | 0.00% | -50.0% |
| Q1 2021 | $8,091,000 | +24.6% | 452,761 | -5.8% | 0.00% | +100.0% |
| Q4 2020 | $6,494,000 | +11.8% | 480,696 | -2.6% | 0.00% | 0.0% |
| Q3 2020 | $5,810,000 | -23.4% | 493,690 | -3.9% | 0.00% | -50.0% |
| Q2 2020 | $7,586,000 | +5.0% | 513,860 | -4.0% | 0.00% | 0.0% |
| Q1 2020 | $7,224,000 | -43.6% | 535,150 | +1.0% | 0.00% | -33.3% |
| Q4 2019 | $12,808,000 | +14.1% | 529,888 | -9.3% | 0.00% | 0.0% |
| Q3 2019 | $11,229,000 | -17.2% | 584,204 | +27.4% | 0.00% | 0.0% |
| Q2 2019 | $13,555,000 | -42.6% | 458,697 | -7.7% | 0.00% | -50.0% |
| Q1 2019 | $23,601,000 | +40.1% | 496,862 | +6.5% | 0.01% | +20.0% |
| Q4 2018 | $16,846,000 | -41.7% | 466,647 | -0.6% | 0.01% | -28.6% |
| Q3 2018 | $28,903,000 | -6.6% | 469,564 | +2.5% | 0.01% | -12.5% |
| Q2 2018 | $30,954,000 | +31.6% | 458,235 | +5.7% | 0.01% | +33.3% |
| Q1 2018 | $23,520,000 | -7.6% | 433,548 | +1.7% | 0.01% | 0.0% |
| Q4 2017 | $25,465,000 | +23.0% | 426,200 | +0.0% | 0.01% | +20.0% |
| Q3 2017 | $20,706,000 | -2.7% | 426,036 | +5.2% | 0.01% | -16.7% |
| Q2 2017 | $21,289,000 | +23.6% | 405,116 | +6.6% | 0.01% | +20.0% |
| Q1 2017 | $17,227,000 | +22.5% | 379,862 | +2.2% | 0.01% | +25.0% |
| Q4 2016 | $14,068,000 | +10.9% | 371,700 | +10.6% | 0.00% | 0.0% |
| Q3 2016 | $12,686,000 | +118.2% | 336,128 | +1.7% | 0.00% | +100.0% |
| Q2 2016 | $5,814,000 | +66.1% | 330,379 | +19.5% | 0.00% | +100.0% |
| Q1 2016 | $3,501,000 | -48.1% | 276,441 | -0.3% | 0.00% | -50.0% |
| Q4 2015 | $6,751,000 | +49.0% | 277,248 | +8.5% | 0.00% | 0.0% |
| Q3 2015 | $4,532,000 | +83.3% | 255,499 | +82.4% | 0.00% | +100.0% |
| Q2 2015 | $2,472,000 | -46.7% | 140,090 | -5.3% | 0.00% | 0.0% |
| Q1 2015 | $4,637,000 | +16.0% | 147,953 | +8.0% | 0.00% | 0.0% |
| Q4 2014 | $3,999,000 | +42.0% | 136,998 | +0.6% | 0.00% | 0.0% |
| Q3 2014 | $2,817,000 | +20.6% | 136,152 | +44.5% | 0.00% | 0.0% |
| Q2 2014 | $2,335,000 | +17.7% | 94,249 | +0.7% | 0.00% | 0.0% |
| Q1 2014 | $1,984,000 | +6.6% | 93,622 | -9.6% | 0.00% | 0.0% |
| Q4 2013 | $1,861,000 | – | 103,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|